Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV protease inhibitors reported by Pharmacia & Upjohn

July 5, 1996

Glaxo Wellcome, Vertex license anti-HIV patents from Searle

July 5, 1996

Second receptor for HIV infection reported

June 28, 1996

Zithromax approved by FDA for new indication

June 28, 1996

U.S. development of DS-4152 for Kaposi's sarcoma treatment discontinued

June 28, 1996

Sequus' Caelyx approved by European Commission

June 28, 1996

Hybridon's GEM-132 to undergo clinical trials

June 28, 1996

Remune covered under Finnish patent

June 28, 1996

Viramune receives accelerated FDA approval

June 28, 1996

Merck & Co. claims process for synthesizing HIV protease inhibitors

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...